Complete remission was observed in three patients with AML by administration of G‐CSF without the use of anti‐leukemic agents, suggesting the possibility that G‐CSF itself has the potential to lead some AML patients to complete remission [32]. The gene discussed is CSF3; the disease is acute myeloid leukemia.